TABLE-Cyfuse Biomedical - 9-MTH parent results

About this update from Cyfuse Biomedical K.k.

Nov 14 (Reuters)- Cyfuse Biomedical K.K. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 9 months ended 9 months ended Year to Sep 30, 2025 Sep 30, 2024 Dec 31, 2025 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 61 mln 26 mln 302 mln (+135.5 pct) (-11.5 pct) (+455.8 pct) Operating loss 689 mln loss 674 mln loss 1.22 Recurring loss 635 mln loss 662 mln loss 1.14 Net loss 637 mln loss 664 mln loss 1.14 EPS loss 74.69 yen loss 82.80 yen loss 139.64 yen Ann Div NIL NIL -Q2 div NIL NIL -Q4 div NIL NIL NOTE - Cyfuse Biomedical K.K.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T

View stock analysis, news, and events for Cyfuse Biomedical K.k.